3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
45
Breast Neoplasms
15
Leiomyoma
3
Cardiovascular Diseases
3
Polycystic Ovary Syndrome
2
Neoplasms
2
Endometrial Neoplasms
2
Advanced Breast Cancer
2
Stage II Prostate Adenocarcinoma
1
Sexual Dysfunctions, Psychological
1
Sarcopenia
1
Salivary Gland Adenoma, Pleomorphic
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatectomy
1
Prostate Cancer With ≤10 Bone Metastases
1
Prostate Cancer Metastatic Disease
1
Prostate Cancer Metastatic
1
Pelvic Pain
1
Oligometastatic Prostate Carcinoma
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer
1
Metabolic Syndrome
1
Metabolic Diseases
1
Kallmann Syndrome
1
Inflammatory Breast Neoplasms
1
Infertility
1
Hypogonadism
1
Hyperprolactinemia
1
Interventions
Radiosurgery
5
Androgen Antagonists
4
enzalutamide
2
Prednisone
2
Docetaxel
2
talazoparib
1
sipuleucel-T
1
rucaparib
1
olaparib
1
gallium 68 PSMA-11
1
darolutamide
1
cabazitaxel
1
apalutamide
1
XRP6258
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Pluvicto
1
Lutetium-177
1
Lutetium
1
Lenograstim
1
Hematologic Tests
1
Granulocyte Colony-Stimulating Factor
1
Gonadotropin-Releasing Hormone
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostate Cancer Metastatic
×
Gonadotropin-Releasing Hormone
×
Clear all
NCT04983095
2026-02-17
METRO
Umeå University
Phase NA
Recruiting
118 enrolled